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Abstract
Background & Aims—Pancreatic intraepithelial neoplasia (PanIN) are pancreatic cancer
precursor lesions of unclear origin and significance. PanIN aberrantly express sonic hedgehog
(Shh), an initiator of pancreatic cancer, and gastrointestinal mucins. The majority of PanIN are
thought to arise from ducts. We identified a novel ductal compartment that is gathered in gland-
like outpouches (pancreatic duct glands, PDG) of major ducts and characterized its role in injury
and metaplasia.
Methods—The ductal system was analyzed in normal pancreata and chronic pancreatitis in
humans and mice. Anatomy was assessed by serial H&E sections and scanning electron
microscopy of corrosion casts. Expression of mucins and developmental genes and proliferation
were assessed by immunohistochemistry or RT-qPCR. Effects of Shh on ductal cells were
investigated by exposure to Shh in vitro and transgenic misexpression in vivo.
Results—Three-dimensional analysis revealed blind-ending outpouches of ducts in murine and
human pancreata. These PDG are morphologically and molecularly distinct from normal ducts;
even in normal pancreata they display PanIN and metaplastic features such as expression of Shh
and gastric mucins. They express other developmental genes, such as Pdx-1 and Hes-1. In injury,
Shh is upregulated along with gastric mucins. Expansion of the PDG compartment results in a
mucinous metaplasia. Shh promotes this transformation in vitro and in vivo.
Conclusions—PDG are a distinct gland-like mucinous compartment with a distinct molecular
signature. In response to injury PDG undergo a Shh-mediated mucinous gastrointestinal
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tmetaplasia with PanIN-like features. PDG may provide a link between Shh, mucinous metaplasia
and neoplasia.
Background
Chronic injury is linked to carcinogenesis in several tumors, including pancreatic cancer.
Chronic pancreatitis (CP) and pancreatic cancer share the presence of pancreatic
intraepithelial neoplasia (PanIN), believed to be cancer precursors.1 Although the
morphology and molecular signature of PanIN and cancer make a ductal origin likely, their
cellular origin is still under debate; recent studies suggest that at least a part of the lesions
are of acinar origin.2–5 The ductal epithelium itself is poorly characterized and often
discussed as a single population of cells. Better characterization of ductal compartments may
advance our understanding of diseases such as CP and pancreatic cancer. One main
characteristic defining PanIN is an increased, aberrant mucin expression, suggesting
mucinous metaplasia as an early step in carcinogenesis. Little is known about the origin,
onset and underlying molecular events of this metaplasia.
The same genes involved in embryonic development appear to play a role in regeneration
and, through inappropriate regulation, in metaplasia and ultimately neoplasia.6,7 Pdx-1 is
important for early pancreatic development and involved in regeneration.6,8–10 Notch
signaling is involved in pancreatic development, regeneration and neoplasia; its effector
Hes-1 is discussed as a marker of progenitor cells.6,11–13 Sonic hedgehog (Shh) inhibits
pancreatic development and directs the foregut mesoderm toward a gastrointestinal (GI)
fate.14 Shh is aberrantly expressed in PanIN and pancreatic adenocarcinoma, and contributes
to carcinogenesis.15 In contrast to Pdx-1 and Hes-1, Shh has not been previously identified
in the normal pancreas.14,15
Identification of Shh and gastric mucins called our attention to small outpouches of major
ducts in normal pancreata. Here we identify and characterize this novel ductal compartment
which is gathered in outpouches, pancreatic duct glands (PDG). PDG have a unique
molecular signature distinct from the pancreatic epithelium: they retain expression of gastric
mucins and Shh. Additionally, PDG express other developmental genes, such as Pdx-1 and
Hes-1, which are also expressed in other regions of the pancreas. In response to chronic
injury, PDG upregulate developmental genes and proliferative rates and undergo a Shh-
mediated mucinous metaplasia. This response suggests PDG may play a role in pancreatic
duct protection, renewal, metaplasia, and possibly neoplasia.
Materials and Methods
Human Samples were collected and analyzed in accordance with IRB approval.
Histologically normal control pancreata (n=8) were obtained from n=6 organ donors (21–48
years) or from patients who underwent pancreaticoduodenectomy for extrapancreatic disease
(n=2, one duodenal cancer and one bile duct cancer). Histologically confirmed human CP
samples were obtained from pancreaticoduodenectomy specimens at the MGH (n=10).
Mouse Samples—All experiments were approved by the MGH Subcommittee on
Research Animal Care. Healthy CD-1 mice (Charles River) served as controls (n=10). Acute
pancreatitis was induced in CD-1 mice of either sex, by 6 hourly intraperitoneal injections of
50 μ g/kg cerulein (Sigma). Chronic pancreatic injury2,16 was induced by 3 series of
injections per week for periods of 3 (n=10), 6 (n=4), 10 (n=3), and 18 (n=2) weeks in CD-1
mice and Ptch1-LacZ reporter mice. Pancreatawere harvested 72 hours after the last
injection using a microsurgical microscope (Codman Microsystems, magnification 15–45x).
Proliferation was assessed by immunostaing after in vivo pulse labeling by intraperitoneal
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tinjection of bromodeoxyuridine (BrdU, Sigma) at 1 mg/10 g body weight 2–3 hrs prior to
harvesting. Positive and negative nuclei were counted in two high-power fields per sample
in 4 samples per group.
Shh-misexpressing Transgenic Mice—Pdx-Shh mice were generated by pronuclear
injection as previously described.15
Histology and Immunohistochemistry
Specimens were fixed overnight in 4% paraformaldehyde or 10% formalin/PBS. Histologic
analysis was performed on 3–4 μ m paraffin-embedded sections by an experienced GI
pathologist (G.Y.L.). Mucins were detected using Alcian blue (pH 2.8) and periodic acid-
Schiff stains. Primary antibodies and conditions for immunohistochemistry are specified in
Supplementary Table 1. Endogenous peroxidase activity was quenched by 3% H2O2.
Biotinylated secondary antibodies were applied at 1:1000 dilution. Proteins were visualized
by brown pigmentation using DAB (Zymed). Slides were counterstained with hematoxylin.
Ptch1 expression was identified in Ptch1-LacZ animals by staining with the LacZ substrate
5-bromo-4-chloro-3-indolyl β -D-galactoside (X-Gal) (Sigma). Specimens were prefixed for
75–90 min in 4% paraformaldehyde at 4°C, washed in buffer and incubated in X-Gal
solution containing protease inhibitors at room temperature for 24 hours. Specimens were
post-fixed in 4% paraformaldehyde for 4 hours, dehydrated, paraffin-embedded, sectioned
and counterstained with nuclear-fast red. Age-matched wild-type littermates were negative
controls.
Casts of the Ductal System
Corrosion casts of the ductal system of five murine pancreata and one human pancreas from
organ donation were obtained by intraductal infusion of the casting medium (Mercox Resin,
Ladd Research Industries, diluted with 10% methyl methacrylate monomer). The resin-filled
tissue was immersed in hot water (60°C) for one hour for resin curing. Tissue was then
removed by maceration in alternating rinses of 5–10% KOH and hot water, cleaned in
formic acid, washed in distilled water and lyophilized. Casts were imaged by light
microscopy and then sputter-coated (Hummer V, Anatech) with gold/platinum for scanning
electron microscopy (SEM) with a LEO 1450VP scanning electron microscope (Carl Zeiss)
at 15kV.
Quantitative Real-time PCR
RNA was extracted (RNA Isolation Kit, Ambion) from tissues stored at −20°C in RNAlater
(Ambion). One-step multiplex TaqMan Real-time RT-PCR was performed using an ABI
7700 Sequence Detector system. Expression of SHH, IHH, DHH, PTCH, SMO, GLI1 and
GLI2 was evaluated using 18S RNA as internal control. Probes and primers were designed
to span exon-exon junctions to avoid amplification of genomic DNA. The thermal cycler
conditions were: Reverse transcription for 30 minutes at 48°C, initial activation step for 10
minutes at 95°C, followed by 40 cycles of denaturation for 15 seconds at 95°C and
annealing/extension for 60 seconds at 60°C. Fluorescence data were collected during
annealing and analyzed using SDS1.7 software (Applied Biosystems). Relative gene
expression was determined based on corresponding Ct (threshold cycle) values.
In vitro SHH experiments
Human pancreatic ductal epithelial (HPDE) cells17,18 were cultured in keratinocyte serum-
free media supplemented with bovine pituitary extract and human epidermal growth factor
(GIBCO, Invitrogen). Cells were exposed to 0, 5, 10, or 20 nM recombinant human SHH
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t(R&D Systems) in culture media. Media was changed every 48 hrs. After 8 days (192 hrs),
cells were stained for PAS and total RNA was harvested for analysis by RTq-PCR.
Statistics
Statistical analysis was performed using GraphPad Prism4 software. Proliferation in PDG
vs. main ducts was compared using 2-way contingency table analyses and Chi-square and
Fisher exact tests. Quantitative gene expression is given as -fold expression over mean
expression in normal pancreata or control cells. The Wilcoxon matched pairs test was used
for comparison of main duct versus parenchymal tissue. P-values are two-tailed.
Results
Pancreatic Ducts Have Blind-ending Outpouches: Pancreatic Duct Glands
H&E stains of serial sections were used to morphologically assess the normal pancreatic
ductal system in healthy mice and normal human pancreata. In both mice and humans, an
epithelial compartment morphologically distinct from the normal ductal epithelium was
identified. This unique compartment appears as either gland-like outpouches or coiled
structures residing within the mesenchyme surrounding larger ducts (Fig. 1). The epithelial
lining of these structures is composed of cells with basally located nuclei and abundant
supranuclear cytoplasm. Comparison of proximal (near the papilla) and peripheral ducts
revealed that these branches/outpouches are more frequent in proximal ducts. Histologic
evaluation of 3μ m serial sections suggested that these structures are blind-ending
outpouches rather than branches (supplemental Fig. 1&2).
To reliably distinguish blind-ending “glands” from small branch ducts based on 3-
dimensional information, we used SEM of ductal corrosion casts. We obtained detailed,
high-resolution casts of the entire ductal system of five mice and one human (Fig. 2 A&B).
Ramification in both the human and rodent pancreas is hierarchical: large interlobular ducts
branch off the main duct and into smaller interlobular ducts, which then branch again into
smaller ducts (Fig. 2 C&D). Multiple small branches of large ducts do not exist. SEM
directly confirmed the presence of outpouches in the ductal system of mice and humans
(Fig. 2E). The distribution of these outpouches is not uniform: in mice, outpouches are
frequently found in the biliopancreatic duct, in the main duct draining the left part of the
pancreas, and in proximal interlobular ducts. Outpouches are less frequently observed in
small pancreatic ducts. Interestingly, outpouches are often located near ductal branching
sites (Fig. 2E). Overall, this distribution results in a proximal pattern with a decreasing
frequency from large toward small ducts. The distribution of outpouches in humans is
similar, but they are observed less frequently than in rodents. Outpouches can have a single
lumen or display a complex arrangement of several sac-like dilatations (lower panels in Fig.
2E).
These SEM data confirm the existence of a unique gland-like ductal compartment which we
will henceforth call Pancreatic Duct Glands (PDG). The existence of specialized duct-
associated glands raises the question of their function and their role in pancreatic disease.
PDG Undergo Hyperplasia in Response to Chronic Injury
The entire ductal system was assessed for morphologic changes induced by a well-
established murine model of chronic pancreatic injury.2,16
Chronic injury for 6 or more weeks results in severe changes in both ductal epithelium and
mesenchyme; PDG change in both frequency and morphology (Fig. 3). Controls have a thin
mesenchymal wall surrounding the proximal ducts, with few PDG. PDG are small, often
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thave a single lumen, and only rarely display several glandular units (Fig. 3A). In response to
chronic injury the ductal mesenchyme thickens. PDG increase in both number and size and
display an often complex architecture, with branching and folds as well as features of atypia
such as papillations and nuclear pseudostratification (Fig. 3B). The epithelium takes on a
more mucinous appearance. These PanIN-like features are more frequently found in PDG of
larger ducts, but can be detected scattered in peripheral ducts.
Thus, in response to chronic injury PDG appear to undergo hyperplasia and develop a
mucinous metaplasia with PanIN-like features.
PDG Retain GI Mucins and Are a Source of GI Metaplasia
Metaplastic ductal lesions, including PanIN and cancer, frequently express GI markers.19,20
Normal pancreatic ducts express PAS+, but not Alcian-blue+ mucins. In contrast,
metaplastic lesions frequently express Alcian blue+ mucins and gastric Muc5ac, which is
considered an early sign of metaplasia.19,21 To determine whether PDG are a possible
source, their mucin expression patterns were characterized in normal and injured pancreata
and compared to normal pancreatic and GI epithelium.
Results in mice (Fig. 4) closely mirror results in humans (Suppl. Fig. 3). PAS+ mucins and
Muc1 are present at the luminal membrane in the entire ductal system (Fig. 4A). However,
only PDG exhibit intense cytoplasmic PAS staining, suggesting a function in mucin
secretion (Fig. 4B). Moreover, PDG express Alcian blue+ mucins, including mucins which
are normally found in the deep part of the gastric pyloric glands, namely Muc6 (Fig. 4
B&E). Thus, PDG in the normal pancreas express mucins which so far have been considered
metaplastic. In response to chronic injury, PDG appear hyperplastic, and exhibit not only an
upregulation and expansion of Muc6 but also de novo expression of Muc5ac, resulting in a
mucinous metaplasia (Fig. 4 C&D). Whereas the gastric Muc5ac is frequently found in PDG
in response to injury, de novo expression of the intestinal Muc2 is observed only rarely.
Mucin expression patterns confirm that PDG are distinct from the rest of the pancreatic
ductal epithelium and undergo a progressive mucinous metaplasia which closely
recapitulates features of the gastric pyloric epithelium.
PDG Retain and Upregulate Developmental Pathways, Including Shh
The pancreatic ductal epithelium has a low turnover rate, and little is known about its
regeneration. In many tissues regeneration and the formation of metaplasia are controlled by
the same genes that direct tissue differentiation during development.7 Our next step,
therefore, was to analyze PDG for the expression of developmental genes known to play a
key role in pancreatic development and disease. Expression of Hh pathway genes as well as
Pdx-1 and Hes-1 was analyzed in controls and in response to chronic injury in the same
mice used previously. Additionally, proliferative activity was analyzed by Ki-67 expression
or BrdU incorporation.
Normal Pancreas—In contrast to previous studies, which had not identified Shh in
normal pancreas, Shh was identified specifically and only in PDG (Fig. 5A). In Ptch1-LacZ
animals, the Hh receptor Ptch1 was identified in the ductal mesenchyme surrounding PDG.
The Ptch2 receptor is co-expressed with Shh in the epithelium of PDG and in single cells of
the normal ductal epithelium. Pdx-1 is expressed predominantly in PDG, but can also be
found in the epithelial lining of the main lumen. Hes-1, which is known to be expressed in
peripheral ducts and centroacinar cells,12 is predominantly expressed in PDG in larger ducts
(Fig. 5A).
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tChronic Injury—In response to chronic injury, all three pathways appear upregulated with
different patterns (Fig. 5B&C). Shh appears to be upregulated, but remains specific to
mucinous metaplastic PDG. Additionally, Shh was focally observed in mucinous lesions
located in the periphery. Ptch1 expression was expanded in the fibrotic ductal mesenchyme,
and Ptch2 expression in PDG and in the main ductal epithelium. Expression of both Pdx-1
and Hes-1 was expanded throughout the ductal epithelium, but Pdx-1 maintained a more
proximal, Hes-1 a more peripheral predominance. All developmental genes remained
expressed in severely metaplastic PDG (Fig. 5C).
Proliferation—In contrast to the GI epithelium, the pancreatic ductal epithelium has a low
turnover rate. In controls proliferation is only occasionally detected in the ductal epithelium,
including PDG (Fig. 5D). In response to injury, proliferation was predominantly localized to
PDG. In ducts with pronounced metaplasia, Ki-67 demonstrated proliferative activity
predominantly in PDG and in the deep portion of mucosal folds and was lost toward the
surface. In response to injury, BrdU+ or Ki-67+ nuclei were significantly more frequent in
PDG compared to the ductal lining (p<0.001; Odds Ratio 6.6 (3.9–11.0) for acute injury and
14.0 (8.2–24.1) for chronic injury).
Results in human pancreata (supplemental Fig. 4) reflect the observations made in the
mouse.
Evidence for Peripheral PDG
To search for peripheral PDG, the markers specific for the PDG compartment, Shh, Alcian
blue and gastric mucins, were assessed in peripheral ducts of control mice and mice with
chronic injury. None of these markers could be identified in small pancreatic ducts in
controls; but outpouches co-expressing these markers could be identified in the thickened
mesenchyme of both small interlobular (Fig 6A) and intralobular ducts (Fig. 6B) in response
to chronic injury, suggesting that their presence is likely too small to be identified in a non-
hyperplastic state.
Shh Misdirects Pancreatic Ducts Toward a GI Mucinous Metaplasia
In development, Shh directs the foregut mesoderm toward a GI fate; in the adult, Shh
appears to promote gastric gland differentiation,22 and has been identified as an early
mediator of pancreatic carcinogenesis.15 The strict co-localization of Shh and gastric-type
mucinous metaplasia in PDG led us to hypothesize that inappropriate upregulation of Shh
may be responsible for the metaplasia seen in chronic injury by directing the pancreatic
ductal epithelium towards a gastric fate. HPDE cells transfected with the Hh effector Gli1
upregulate foregut markers23. We aimed to determine whether the pancreatic ductal
epithelium is directly responsive to the ligand Shh and whether increased levels of Shh can
drive a gastric mucinous metaplasia.
HPDE cells17,18 were exposed to recombinant Shh and analyzed for Ptch and mucin
expression. HPDE exposed to recombinant SHH for 8 days showed a phenotypical change
with enhanced mucin expression compared to control cells (Fig. 7A). Quantitative RT-PCR
revealed that HPDE cells express the Hh receptor and downstream gene PTCH2 and
upregulate this expression in response to Shh exposure, demonstrating Hh pathway
activation. Moreover, HPDE cells upregulate expression of the gastric mucins MUC6 and
especially MUC5ac (Fig. 7A). Thus, HPDE cells are responsive to the ligand Shh and
undergo gastric mucinous transformation after Hh pathway activation in vitro.
To analyze whether Shh has similar effects in vivo, we evaluated the effects of engineered
Shh misexpression on phenotype and mucin expression of pancreatic ducts. Analysis of
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tpancreata from Pdx-Shh transgenic mice demonstrated that the ductal epithelium first has a
non-mucinous appearance and secondarily develops a mucinous metaplasia. Again, this
Shh-mediated metaplasia is characterized by expression of gastric mucins, such as Muc5ac
(Fig. 7B).
In vitro and in vivo results demonstrate that the adult pancreatic ductal epithelium is
responsive to Shh signalling and that enhanced levels of Shh are sufficient to drive a GI
mucinous metaplasia. Thus PDG-derived Shh may drive mucinous metaplasia and PanIN-
like formation in pancreatic disease.
PDG Display SHH Upregulation and Metaplasia in Human Chronic Pancreatitis
To assess the relevance of our findings to human disease, we analyzed Shh expression and
metaplastic changes in human pancreata.
SHH was not detected in peripheral pancreatic ducts, acini or islets of normal human
pancreata (n=8). However, SHH is expressed in PDG (Fig. 8A). In CP (n=6) SHH appears
upregulated. In all pancreata evaluated SHH was aberrantly expressed at a much higher level
in an expanded, morphologically hyperplastic epithelium exhibiting increased mucin
expression and cellular atypia, features of PanIN (Fig. 8A). Comparison of proximal (Fig.
8A) to peripheral ducts (Fig. 8B) revealed that these changes are present focally throughout
the ductal epithelium but have a proximal predominance. SHH expression in peripheral
ducts was always co-localized with mucinous metaplasia or atypia.
RTq-PCR was performed for the Hh pathway (Fig. 8C). In normal pancreata (n=6) all Hh
transcripts were detected at a low level. In CP (n=10), the entire pathway, including ligands,
receptors, and transcription factors, was upregulated. Although all three ligands were
identified, SHH had the highest upregulation. Expression of Shh and its pathway members is
found at much higher levels in biopsies of proximal ducts compared to matched peripheral
biopsies. Whereas by immunostaining the enhanced expression of Shh appears to be
localized to the metaplastic epithelium, upregulation of the downstream genes may also
involve the mesenchyme.
Together immunostaining and RT-PCR confirm that SHH remains expressed in the PDG
compartment in human pancreata and suggest that in the human SHH has effects similar to
those shown in mice.
Conclusions
The pancreatic ductal epithelium is a heterogeneous group of cells. We present evidence that
this epithelium harbors a specialized compartment, pancreatic duct glands. In its normal
state this compartment retains expression of developmental markers, including Shh, and is a
site of production of gastric-type mucins. In response to chronic injury, the compartment is a
source of a Shh-mediated gastric mucinous metaplasia.
Specialized mucin-producing glands in the pancreas were first noted in the 1960s.24 In the
1980s Bock et al. investigated secretory cells within pancreatic ducts by electron microscopy
and by their histochemical staining pattern. They found that mucin-producing cells were
gathered in mucosal folds, forming endo-epithelial glands which they called “duct
glands.”25–27 However their anatomic character as blind-ending structures could not be
conclusively elucidated. This compartment and its role in injury have not been further
analyzed until now.
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tIn the present study, SEM of ductal corrosion casts allowed to directly demonstrated in both
rodents and humans that these structures are blind-ending outpouches. PDG have a greater
prevalence in rodents than in humans, consistent with inter-species variability in the
frequency of mucin-producing cells.24 The predominant cells in these glands are mucin-
producing and have basally located nuclei and abundant supranuclear cytoplasm. This
morphology resembles PanIN-1A. Because PanIN-1A may be seen in otherwise normal
pancreata, the original PanIN classification acknowledges the possible existence of non-
neoplastic “lesions” in normal pancreata, referred to as PanIN/L-1A1. Our data suggest that
PDG may account for at least a subset of such early PanIN and may be the origin of later
PanIN.
The existence of “pancreatic duct glands” raises the question of their function. Clearly, they
are a specific site of mucin production which serves for mucosal protection. Because ductal
cell turnover in the normal pancreas is low, studies investigating its renewal are difficult and
little is known about renewal of the pancreatic ductal epithelium. In a study of the ductal
epithelium in human CP, expression patterns of growth factors identified a specialized
epithelium which buds off the main lumen and was suggested to play a role in repair.28 In
rodent models of pancreatic injury Pdx-1 is induced in the main duct and “small
evaginations”.10,29 PDG express and upregulate several of the genes that mark progenitor
cells in intestinal crypts, Shh, Pdx-1 and Hes-1. Although the proliferation data and the
expression of developmental markers show that, unlike intestinal crypts, PDG are not the
exclusive site of cells likely to be involved in epithelial renewal, their predominance in PDG
suggests that PDG contribute to epithelial renewal and repair.
Dysregulation of mechanisms involved in regeneration and repair can lead to metaplasia and
ultimately neoplasia.7 In the pancreas, the Hh pathway is involved in regeneration.30 Its
ligand Shh has been identified as an initiator of neoplasia.15 Most recently Shh has been
identified in pancreatic cancer stem cells.31,32 The finding that Shh remains expressed in
PDG, that exhibit features of “metaplasia” may explain prior observations of Shh and GI
marker expression in early PanIN even in the absence of other signs of atypia or alterations
of other cancer-related genes. The finding that the PDG compartment is particularly prone to
Shh-mediated GI metaplasia in response to injury suggests both a source and mechanism of
metaplasia in the diseased pancreas. Interestingly, injured human and mouse pancreata
exhibit a highly organized gastric-type metaplasia that closely mirrors the mucin expression
pattern of the pylorus. Although this is speculative, we may propose that Shh-mediated
metaplasia in the pancreas may play a similar role to that described for CDX-1-mediated
intestinal metaplasia in the stomach and esophagus, and may, like Barrett’s metaplasia,33,34
be associated with the risk for cancer.
Recent attention has focused on the importance of paracrine Hh signaling for desmoplasia
and pancreatic cancer progression.35,36 In a recent study by Tian et al. Hh ligands were
expressed in the epithelium but only the stromal compartment was found to be able to
transduce downstream pathway activity during pancreatic carcinogenesis.37 Similar to our
study, Tian et al. used the Ptch1-LacZ mouse and – mirroring our results – Hh pathway
activity was reported exclusively in the mesenchyme37. During development Ptch1 is
preferentially expressed in the mesenchyme, whereas the Ptch2 homologue is co-expressed
with Shh in the epithelium.38 Our data suggest that this differential expression of Ptch
receptors is maintained into adulthood. In response to chronic injury, we found enhanced co-
expression of Ptch2 along with Shh in PDG and in the ductal surface epithelium, whereas
Ptch1 was expressed in the fibrotic stroma. Ptch2 expression and upregulation in the surface
epithelium in vivo and in HPDE cells in vitro demonstrate that PDG-derived Shh can
influence responsive target cells not only in PDG, but in the entire ductal epithelium,
similarly as suggested for growth factor signaling.28 Whereas we focused on the epithelial
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paracrine stromal Hh activation35–37 via the Ptch1 receptor may represent a parallel and
even predominant mechanism of Hh activation within the entire tissue. At present, the exact
role of Hh signaling in the complexity of epithelial-mesenchymal interactions remains to be
understood.
Although much work must still be done to confirm the role of PDG in protection,
regeneration and cancer, it is clear that they represent a distinct gland-like compartment,
principally located in the proximal ductal system, which has a distinct molecular signature
and is different from the normal pancreatic ductal epithelium. PDG may thus provide a link
between injury, Shh-activation, mucinous metaplasia and neoplasia and represent a possible
cell of origin.
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tFigure 1.
Morphologically distinct ductal compartment. Normal mouse (A) and human (B) pancreas.
Cells with abundant supranuclear cytoplasm and basally located nuclei (arrowheads) are
located in outpouches/small branches (arrowheads) within the ductal wall mesenchyme. This
compartment is morphologically distinct from the epithelial lining of the adjacent main
lumen (asterisk) and peripheral ducts of comparable size (lower panels). (C) Serial sections
reveal that the novel compartment has unique molecular features, such as expression of
Muc6 (brown).
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Corrosion casts reveal that ducts have blind-ending outpouches: pancreatic duct glands. (A,
B) Overviews show complete corrosion casts of the ductal system of (A) mouse and (B)
human. (C, D) Light microscopy demonstrates hierarchical ramification of the ductal system
rather than multiple small branches of larger ducts. (E) SEM reveals that pancreatic ducts
have small gland-like outpouches, often located near branching points (arrowheads). They
are predominantly found in large ducts (upper panels) but can be observed in small ducts
(mid panels). These glands can appear as single outpouches or exhibit a complex
arrangement of several sac-like dilations (lower panels).
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tFigure 3.
PDG undergo hyperplasia in response to chronic injury. Overviews of the proximal ductal
systems of a control animal (A) and an animal with chronic injury and metaplasia (B). (A)
The normal pancreas has few, small PDG (arrows) with a regular, single-layer lining of
mucinous appearance (insets) in a thin ductal mesenchyme. (B) In chronic injury PDG
significantly increase in both number and size (arrows). PDG exhibit hyperplasia, a complex
morphology (asterisk) and are lined by a less regular epithelium with several layers and
papillations (insets). Changes are more pronounced in proximal PDG. The ductal
mesenchyme is thickened.
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Mouse pancreas: PDG retain GI mucins and are a source of GI mucinous metaplasia. (A)
Normal peripheral pancreatic ducts have a cuboidal to low columnar epithelium with low
expression of PAS+ mucins (magenta) and Muc-1, but are Alcian blue −. (B) PDG contain a
distinct epithelium with PAS+ and Alcian blue+ (turquoise) mucins. PDG, but not the lining
of the main lumen (below), express mucins normally found in the deep gastric mucosa (low
panels) (GI tract in E). (C, D) In chronic injury, PDG hypertrophy, along with increased
mucin expression and morphologic atypia. Gastric mucins are upregulated (lower two rows).
Muc5ac is frequently, Muc2 rarely expressed. This results in a metaplastic phenotype
resembling the pyloric region (E), rather than normal pancreatic ducts (A).
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PDG are a preferential site of expression of developmental factors and of proliferation. (A)
In the normal state, Shh is expressed at a low level specifically in PDG (arrowheads), but
not in the luminar epithelium. The receptor Ptch2 is co-expressed with Shh in PDG and
additionally in some cells of the ductal surface epithelium (arrowheads); Ptch1 is expressed
in the mesenchyme around PDG. Pdx-1 is expressed predominantly in PDG (arrowheads)
but can be identified in the ductal epithelium. Hes-1 is expressed predominantly in PDG
within large ducts (arrowheads) but can be identified throughout the ductal epithelium. (B)
In response to chronic injury, all these markers appear upregulated. Shh remains specific to
mucinous cells within PDG. Ptch2 is expressed in PDG but expanded in surface epithelium
(arrowheads); Ptch1 is generalized in the ductal mesenchyme. Expression of Pdx-1 and
Hes-1 is expanded or generalized in the ductal epithelium. (C) In severe metaplasia and
atypia these changes are more pronounced. Shh remains specific for the mucinous
epithelium. Pdx-1 and Hes-1 are expanded to the surface epithelium, but remain strongly
expressed in the deeper epithelium. (D) In response to injury, proliferation (BrdU
incorporation) in large ducts is predominantly located to PDG (arrows). In chronic injury
and metaplasia, expression of the proliferation marker Ki-67 is identified predominantly in
PDG and the apex of mucosal folds. MD: Main duct epithelial lining.
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The PDG compartment exists in peripheral ducts. In chronic injury Shh, Alcian blue and
Muc6 identify the PDG-compartment in the mesenchyme of interlobular (A) and small
intralobular (B) ducts.
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Shh misdirects the pancreatic ductal epithelium toward a GI mucinous metaplasia. (A) Shh
exposure results in enhanced mucin expression (PAS: magenta, arrowheads) in HPDE cells.
Real-time quantitative RT-PCR reveals that HPDE cells are Hh target cells expressing the
receptor PTCH2. In response to Shh exposure the pathway is activated (PTCH2
upregulation) along with upregulation of gastric mucins (MUC5ac, MUC6). (B) Transgenic
misexpression of Shh in Pdx-Shh mice results in a GI phenotype of pancreatic ducts with
expression of PAS+ (magenta) and Alcian blue+ mucins, including Muc5ac. Scale bars
indicate 100μ m.
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tFigure 8.
SHH is expressed in human PDG and upregulated in metaplasia. (A) PDG of the main duct.
Control: SHH is expressed at a low level in PDG (arrowheads). PAS staining (magenta)
identifies co-expression of mucins. CP: H&E reveals hypertrophic outpouches/branches
exhibiting papillary formations (arrowheads) and pseudo-stratified nuclei (arrow), features
of PanIN. SHH is upregulated, identified by brown supranuclear granular staining. PAS
reveals enhanced mucin expression. (B) Control: Peripheral ducts have cuboidal epithelium
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twithout Shh expression and with minimal expression of mucins. CP: Atypical peripheral
ducts with PanIN features (arrow, arrowheads) express SHH (arrowheads) along with
increased mucin expression. Scale bars indicate 100μ m. (C) Expression of HH pathway
genes in CP shown as -fold expression over normal pancreata. Shh and the effectors Gli-1
and Gli-2 are significantly upregulated. Receptor genes PTCH1 and SMO are upregulated to
a lesser extent. Comparison of expression levels in main duct tissue (black bars) vs.
peripheral parenchyma (white bars) reveals that HH pathway activation is mainly localized
to the proximal ductal system. Error bars indicate S.E.M. *, P < 0.05.
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